Delphine Garnier

2.6k total citations
44 papers, 2.1k citations indexed

About

Delphine Garnier is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Delphine Garnier has authored 44 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 17 papers in Cancer Research and 14 papers in Genetics. Recurrent topics in Delphine Garnier's work include Extracellular vesicles in disease (17 papers), MicroRNA in disease regulation (11 papers) and Glioma Diagnosis and Treatment (10 papers). Delphine Garnier is often cited by papers focused on Extracellular vesicles in disease (17 papers), MicroRNA in disease regulation (11 papers) and Glioma Diagnosis and Treatment (10 papers). Delphine Garnier collaborates with scholars based in Canada, France and United States. Delphine Garnier's co-authors include Janusz Rak, Brian Meehan, Nathalie Magnus, Tae Hoon Lee, Laura Montermini, Esterina D’Asti, Christiane Guguen‐Guillouzo, Anne Corlu, Thomas Kislinger and Chlöe Milsom and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Delphine Garnier

43 papers receiving 2.1k citations

Peers

Delphine Garnier
Vanessa Chisholm United States
Marya F. McCarty United States
Lynne Krummen United States
Felix Bachmann Switzerland
Kin-Ming Lo United States
Vanessa Chisholm United States
Delphine Garnier
Citations per year, relative to Delphine Garnier Delphine Garnier (= 1×) peers Vanessa Chisholm

Countries citing papers authored by Delphine Garnier

Since Specialization
Citations

This map shows the geographic impact of Delphine Garnier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Delphine Garnier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Delphine Garnier more than expected).

Fields of papers citing papers by Delphine Garnier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Delphine Garnier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Delphine Garnier. The network helps show where Delphine Garnier may publish in the future.

Co-authorship network of co-authors of Delphine Garnier

This figure shows the co-authorship network connecting the top 25 collaborators of Delphine Garnier. A scholar is included among the top collaborators of Delphine Garnier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Delphine Garnier. Delphine Garnier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meehan, Brian, Lata Adnani, Xianbing Zhu, et al.. (2025). Curative timed NK cell-based immunochemotherapy aborts brain tumour recurrence driven by mesenchymal glioma stem cells. Acta Neuropathologica Communications. 13(1). 64–64. 1 indexed citations
2.
Davi, Frédéric, Letícia Koch Lerner, Delphine Garnier, et al.. (2023). del(8p) and TNFRSF10B loss are associated with a poor prognosis and resistance to fludarabine in chronic lymphocytic leukemia. Leukemia. 37(11). 2221–2230. 2 indexed citations
3.
Nemazanyy, Ivan, Damien Roos‐Weil, Karim Maloum, et al.. (2023). ACOX1-mediated peroxisomal fatty acid oxidation contributes to metabolic reprogramming and survival in chronic lymphocytic leukemia. Leukemia. 38(2). 302–317. 11 indexed citations
4.
Bauvois, Brigitte, et al.. (2023). Extracellular Vesicles in Chronic Lymphocytic Leukemia: Tumor Microenvironment Messengers as a Basis for New Targeted Therapies?. Cancers. 15(8). 2307–2307. 11 indexed citations
5.
Belmonte-Beitia, Juan, Gabriel F. Calvo, Catherine Gratas, et al.. (2020). Mitochondria transfer from tumor-activated stromal cells (TASC) to primary Glioblastoma cells. Biochemical and Biophysical Research Communications. 533(1). 139–147. 60 indexed citations
6.
Delavallée, Laure, Lauriane Cabon, Aurélien Mazeraud, et al.. (2020). Mitochondrial AIF loss causes metabolic reprogramming, caspase-independent cell death blockade, embryonic lethality, and perinatal hydrocephalus. Molecular Metabolism. 40. 101027–101027. 20 indexed citations
7.
Guyon, Nina, Delphine Garnier, Arulraj Nadaradjane, et al.. (2020). Anti-PD1 therapy induces lymphocyte-derived exosomal miRNA-4315 release inhibiting Bim-mediated apoptosis of tumor cells. Cell Death and Disease. 11(12). 1048–1048. 29 indexed citations
8.
Garnier, Delphine, et al.. (2019). The Heterogeneity of Osteosarcoma: The Role Played by Cancer Stem Cells. Advances in experimental medicine and biology. 1139. 187–200. 39 indexed citations
9.
El-Habr, Elias A., Delphine Garnier, Hervé Chneiweiss, et al.. (2019). Capture at the single cell level of metabolic modules distinguishing aggressive and indolent glioblastoma cells. Acta Neuropathologica Communications. 7(1). 155–155. 22 indexed citations
10.
Ménoret, Séverine, Laure‐Hélène Ouisse, Laurent Tesson, et al.. (2018). Generation of Immunodeficient Rats With Rag1 and Il2rg Gene Deletions and Human Tissue Grafting Models. Transplantation. 102(8). 1271–1278. 21 indexed citations
11.
Garnier, Delphine, Ruoya Li, Frédéric Delbos, et al.. (2018). Expansion of human primary hepatocytes in vitro through their amplification as liver progenitors in a 3D organoid system. Scientific Reports. 8(1). 8222–8222. 52 indexed citations
12.
Waissbluth, Sofia, et al.. (2016). The impact of erdosteine on cisplatin-induced ototoxicity: a proteomics approach. European Archives of Oto-Rhino-Laryngology. 274(3). 1365–1374. 8 indexed citations
13.
Nakano, Ichiro, Delphine Garnier, Mutsuko Minata, & Janusz Rak. (2015). Extracellular vesicles in the biology of brain tumour stem cells – Implications for inter-cellular communication, therapy and biomarker development. Seminars in Cell and Developmental Biology. 40. 17–26. 87 indexed citations
14.
Fang, Yi, Delphine Garnier, Tae Hoon Lee, et al.. (2015). PML–RARa modulates the vascular signature of extracellular vesicles released by acute promyelocytic leukemia cells. Angiogenesis. 19(1). 25–38. 37 indexed citations
15.
Montermini, Laura, Brian Meehan, Delphine Garnier, et al.. (2015). Inhibition of Oncogenic Epidermal Growth Factor Receptor Kinase Triggers Release of Exosome-like Extracellular Vesicles and Impacts Their Phosphoprotein and DNA Content. Journal of Biological Chemistry. 290(40). 24534–24546. 111 indexed citations
16.
Magnus, Nathalie, Delphine Garnier, Brian Meehan, et al.. (2014). Tissue factor expression provokes escape from tumor dormancy and leads to genomic alterations. Proceedings of the National Academy of Sciences. 111(9). 3544–3549. 86 indexed citations
17.
Garnier, Delphine, Nathalie Magnus, Brian Meehan, Thomas Kislinger, & Janusz Rak. (2013). Qualitative changes in the proteome of extracellular vesicles accompanying cancer cell transition to mesenchymal state. Experimental Cell Research. 319(17). 2747–2757. 70 indexed citations
18.
Garnier, Delphine, Nathalie Magnus, Tae Hoon Lee, et al.. (2012). Cancer Cells Induced to Express Mesenchymal Phenotype Release Exosome-like Extracellular Vesicles Carrying Tissue Factor. Journal of Biological Chemistry. 287(52). 43565–43572. 121 indexed citations
19.
Garnier, Delphine, Chlöe Milsom, Nathalie Magnus, et al.. (2010). Role of the tissue factor pathway in the biology of tumor initiating cells. Thrombosis Research. 125. S44–S50. 36 indexed citations
20.
Cérec, Virginie, Denise Glaise, Delphine Garnier, et al.. (2007). Transdifferentiation of hepatocyte‐like cells from the human hepatoma HepaRG cell line through bipotent progenitor†. Hepatology. 45(4). 957–967. 279 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026